drugset / Trial / NCT02813434
Cerebral Amyloid Imaging Using Florbetapir (AV-45)
NaSingle-groupOpen-labelDiagnostic
Summary
This study is aimed at examining the interest of amyloid radiotracer Florbetapir (18F-AV-45) for the etiological diagnosis of poststroke cognitive impairment and dementia
Timeline
- Start
- 2014-09-24
- Primary completion
- 2025-01-07
- Completion
- 2025-01-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | florbetapir | Diagnostic / imaging agent | — | — |